Get 20% off on Global Market Reports until March 31st! Use code FY25SAVE at checkout.

How has the genital warts market size evolved in recent years?

The market size for genital warts has seen robust growth in the recent past. The market is projected to expand from $1.97 billion in 2024 to $2.08 billion in 2025, with a compound annual growth rate (CAGR) of 5.7%. Factors contributing to this growth during the historic period include an amplified focus on patient-oriented care, the endorsement of early diagnosis and treatment, an increase in self-target application therapies, and an uptick in clinical trials and genital warts recurrence.

What are the predictions for the genital warts market size in the coming years?

In the upcoming years, the market size for genital warts is projected to experience substantial growth, increasing to $2.57 billion in 2029 with a compound annual growth rate (CAGR) of 5.4%. The growth during this forecasted time frame can be credited to several factors including, increased application of telemedicine and digital health platforms for remote consultation and treatment monitoring, the rising need for affordable and effective treatments for sexually transmitted infections (STIs), the growing appeal of the loop electrosurgical excision procedures, the surging demand for interferon alfa-n3 injection and the increased availability of treatment options. Additionally, the forecasted period will witness major trends such as advancements in diagnostic technologies, a shift towards combination therapies, further expansion of telehealth and online consultations, the emergence of innovative therapeutic targets, and growth in emerging markets.

Get your genital warts market report here!

https://www.thebusinessresearchcompany.com/report/genital-warts-global-market-report

What key factors are fueling the growth of the genital warts market?

The rise in sexually transmitted infections (STIs) is fueling the expansion of the genital warts market. STIs, which are predominantly passed on through sexual intercourse – vaginal, anal, and oral – are caused by bacteria, viruses, or parasites. The increasing instances of STIs can be attributed to heightened sexual activity, insufficient use of precautionary measures, and restricted access to education and healthcare facilities. Genital warts, a frequently occurring STI, are brought about by specific variants of the human papillomavirus (HPV) and are transmitted through direct skin contact during sexual activity. For instance, in October 2023, the Joint United Nations Programme on HIV/AIDS, a comprehensive program based in Switzerland that aims at preventing HIV infection, reported that the number of HIV-infected individuals rose from 38.7 million in 2021 to 39.0 million in 2022, with an additional 1.3 million people being infected in 2022 alone. Consequently, the escalating prevalence of STIs is propelling the genital warts market’s growth.

How is the global genital warts market divided into key segments?

The genital warts market covered in this report is segmented –

1) By Drug Type: Imiquimod, Podophyllin, Podofilox, Trichloroacetic Acid

2) By Treatment: Chemical Treatment, Ablative Treatment, Preventive Treatment, Other Treatments

3) By Gender: Female, Male

4) By End Users: Hospitals, Clinics, Home Care Settings

Subsegmments

1) By Imiquimod: Imiquimod Cream 5%, Imiquimod Cream 3.75%

2) By Podophyllin: Podophyllin Resin 10%, Podophyllin Resin 25%

3) By Podofilox: Podofilox Gel 0.5%, Podofilox Solution 0.5%

4) By Trichloroacetic Acid: Trichloroacetic Acid 80-90%, Trichloroacetic Acid 50-70%

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=18374&type=smp

Who are the key firms paving the way for growth in the genital warts market?

Major companies operating in the genital warts market are Merck & Co.Inc., AbbVie Inc, Sanofi S.A, Novartis AG, 3M Company, Teva Pharmaceutical Industries Ltd, Bausch Health Companies Inc, Sun Pharmaceuticals, Perrigo Company plc, Glenmark Pharmaceutical Inc, Taro Pharmaceutical Industries Ltd, Serum Institute of India Pvt. Ltd., ANI Pharmaceuticals Inc, Ligand Pharmaceuticals Incorporated, Orgenesis Inc, Verrica Pharmaceuticals Inc, CryoConcepts LP, CryoIQ global AB, Cassiopea Inc, Aresus Pharma Inc.

What key trends are currently impacting the genital warts market’s development?

Prominent corporations within the genital warts market are focusing on creating innovative treatment methodologies, for instance, pioneering dermatology medications, to tackle the issues that genital warts patients face. Dermatology medicines encompass recently formed pharmaceuticals or therapeutic substances specifically crafted to cure numerous dermatological conditions like genital warts. For instance, Verrica Pharmaceuticals Inc., a dermatological pharmaceutical firm based in the US, was granted New Chemical Entity (NCE) status for its drug contender YCANTH in March 2023. YCANTH, which is under development for treating genital warts, has successfully completed phase 2 trials. Having obtained FDA NCE status, the corporation is now guaranteed a minimum five-year protection against competition from generic medications.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=18374

What regions are contributing significantly to the growth of the genital warts market?

North America was the largest region in the genital warts market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the genital warts market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Cryogenic Equipment Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/cryogenic-equipment-global-market-report

Cryogenic Insulation Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/cryogenic-insulation-global-market-report

Cryogenic Tanks Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/cryogenic-tanks-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: